NINTEDANIB

NINTEDANIB was reported 32515 times

NINTEDANIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IDIOPATHIC PULMONARY FIBROSIS 2209 0.5581
1 SYSTEMIC SCLEROSIS PULMONARY 17 0.2931
2 CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE 14 0.2545
3 LUNG DIFFUSION TEST DECREASED 71 0.1779
4 FORCED VITAL CAPACITY DECREASED 107 0.1639
5 COUGH DECREASED 17 0.1278
6 KL-6 INCREASED 28 0.1239
7 BENDOPNOEA 22 0.1000
8 OXYGEN SATURATION INCREASED 33 0.0973
9 OXYGEN CONSUMPTION 15 0.0926
10 POST-TUSSIVE VOMITING 15 0.0920
11 OXYGEN CONSUMPTION INCREASED 175 0.0732
12 LUNG TRANSPLANT 237 0.0669
13 SYSTEMIC SCLERODERMA 45 0.0618
14 WALKING DISTANCE TEST ABNORMAL 23 0.0588
15 DAIRY INTOLERANCE 16 0.0569
16 TOTAL LUNG CAPACITY ABNORMAL 22 0.0566
17 IDIOPATHIC INTERSTITIAL PNEUMONIA 19 0.0537
18 CHRONIC RESPIRATORY FAILURE 63 0.0522
19 PULMONARY FUNCTION TEST ABNORMAL 80 0.0513
20 PULMONARY FUNCTION TEST DECREASED 222 0.0507
21 HYPERSENSITIVITY PNEUMONITIS 57 0.0500
22 TOTAL LUNG CAPACITY DECREASED 79 0.0494
23 DIVERTICULITIS INTESTINAL HAEMORRHAGIC 18 0.0469
24 FAECES SOFT 316 0.0434
25 OXYGEN CONSUMPTION DECREASED 24 0.0396
26 ABNORMAL LOSS OF WEIGHT 244 0.0358
27 PULMONARY FIBROSIS 655 0.0341
28 TELANGIECTASIA 32 0.0332
29 INCREASED VISCOSITY OF BRONCHIAL SECRETION 21 0.0329
30 OXYGEN SATURATION ABNORMAL 89 0.0313
31 SPUTUM INCREASED 67 0.0309
32 DYSPNOEA EXERTIONAL 1151 0.0305
33 PNEUMOMEDIASTINUM 54 0.0299
34 DEPENDENCE ON OXYGEN THERAPY 14 0.0284
35 PNEUMOTHORAX SPONTANEOUS 19 0.0280
36 PRODUCTIVE COUGH 1296 0.0271
37 DIZZINESS EXERTIONAL 20 0.0263
38 SCLERODERMA 81 0.0223
39 PULMONARY PAIN 63 0.0216
40 SPUTUM RETENTION 21 0.0212
41 OXYGEN SATURATION DECREASED 1182 0.0210
42 PNEUMOTHORAX 332 0.0209
43 SQUAMOUS CELL CARCINOMA OF LUNG 16 0.0209
44 PHYSICAL DECONDITIONING 52 0.0202
45 FOOD AVERSION 34 0.0200
46 GASTROINTESTINAL SOUNDS ABNORMAL 98 0.0198
47 SUBCUTANEOUS EMPHYSEMA 19 0.0193
48 SMALL CELL LUNG CANCER 29 0.0192
49 DYSPNOEA AT REST 55 0.0190
50 SPUTUM DISCOLOURED 166 0.0175
51 PULMONARY HYPERTENSION 356 0.0171
52 OXYGEN THERAPY 28 0.0170
53 LUNG OPERATION 14 0.0167
54 FLATULENCE 946 0.0167
55 DIARRHOEA 10539 0.0163
56 SEASONAL ALLERGY 229 0.0162
57 EXERCISE TOLERANCE DECREASED 93 0.0161
58 TASTE DISORDER 317 0.0156
59 DISCOLOURED VOMIT 15 0.0156
60 FIBROSIS 46 0.0149
61 LARGE INTESTINAL HAEMORRHAGE 33 0.0147
62 DIARRHOEA HAEMORRHAGIC 137 0.0146
63 DRUG TOLERANCE DECREASED 40 0.0142
64 BONE CONTUSION 13 0.0142
65 CREPITATIONS 42 0.0141
66 MESENTERIC VEIN THROMBOSIS 14 0.0140
67 HAEMORRHOIDAL HAEMORRHAGE 68 0.0139
68 LIVER FUNCTION TEST INCREASED 296 0.0138
69 DECREASED APPETITE 3188 0.0137
70 GASTROINTESTINAL MOTILITY DISORDER 73 0.0136
71 INTERSTITIAL LUNG DISEASE 660 0.0136
72 COR PULMONALE 13 0.0136
73 SECRETION DISCHARGE 169 0.0135
74 DYSENTERY 25 0.0134
75 RESPIRATORY TRACT IRRITATION 14 0.0134
76 FAECES DISCOLOURED 279 0.0129
77 RESTRICTIVE PULMONARY DISEASE 15 0.0128
78 RESPIRATION ABNORMAL 87 0.0126
79 RALES 73 0.0126
80 INTERNAL HAEMORRHAGE 140 0.0122
81 COUGH 3397 0.0121
82 PARANASAL SINUS HYPERSECRETION 46 0.0120
83 MULTIPLE ALLERGIES 92 0.0117
84 HYPOGEUSIA 23 0.0117
85 LUNG ADENOCARCINOMA 35 0.0116
86 CATHETERISATION CARDIAC 51 0.0115
87 WEIGHT DECREASED 3173 0.0114
88 POST-ACUTE COVID-19 SYNDROME 14 0.0113
89 FAECES HARD 44 0.0113
90 HAEMOPTYSIS 302 0.0108
91 LARGE INTESTINE INFECTION 13 0.0106
92 ANAL INCONTINENCE 95 0.0106
93 UPPER-AIRWAY COUGH SYNDROME 87 0.0105
94 PATIENT DISSATISFACTION WITH TREATMENT 20 0.0104
95 EPISTAXIS 773 0.0103
96 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 25 0.0101
97 CARDIAC ABLATION 18 0.0101
98 ABDOMINAL DISCOMFORT 1683 0.0100
99 URINARY BLADDER HAEMORRHAGE 21 0.0100
100 WRONG DOSE 24 0.0099
101 GASTROINTESTINAL DISORDER 889 0.0099
102 ULCER HAEMORRHAGE 67 0.0099
103 URINE ABNORMALITY 45 0.0099
104 AGEUSIA 246 0.0099
105 BLOOD ELECTROLYTES DECREASED 14 0.0098
106 GASTRIC DISORDER 335 0.0098
107 LUNG DISORDER 477 0.0097
108 GASTROINTESTINAL PAIN 107 0.0097
109 HAEMORRHAGIC DIATHESIS 34 0.0095
110 CARBON DIOXIDE INCREASED 13 0.0095
111 PNEUMATOSIS INTESTINALIS 27 0.0095
112 CHOKING SENSATION 52 0.0094
113 CONSTIPATION 2053 0.0094
114 ABDOMINAL PAIN UPPER 1925 0.0093
115 MOTION SICKNESS 18 0.0093
116 OBLITERATIVE BRONCHIOLITIS 12 0.0091
117 HYPOXIA 315 0.0089
118 HAEMATOCHEZIA 493 0.0089
119 GASTRIC HAEMORRHAGE 102 0.0089
120 RETCHING 188 0.0088
121 AORTIC VALVE REPLACEMENT 11 0.0088
122 RESPIRATORY TRACT CONGESTION 139 0.0087
123 DISEASE COMPLICATION 40 0.0087
124 HEPATIC ENZYME INCREASED 595 0.0087
125 LUNG OPACITY 23 0.0087
126 TONGUE COATED 15 0.0087
127 VOCAL CORD DISORDER 17 0.0086
128 PULMONARY ARTERIAL PRESSURE INCREASED 14 0.0086
129 LACTOSE INTOLERANCE 22 0.0086
130 PULMONARY HAEMORRHAGE 67 0.0086
131 BOWEL MOVEMENT IRREGULARITY 65 0.0085
132 DIVERTICULUM INTESTINAL HAEMORRHAGIC 19 0.0084
133 DIZZINESS POSTURAL 79 0.0081
134 NASAL DRYNESS 51 0.0081
135 HEART VALVE REPLACEMENT 12 0.0081
136 SLEEP DEFICIT 17 0.0080
137 ACUTE RESPIRATORY FAILURE 154 0.0080
138 NON-SMALL CELL LUNG CANCER 38 0.0079
139 POLYMYOSITIS 14 0.0079
140 APPETITE DISORDER 52 0.0078
141 THROAT IRRITATION 351 0.0078
142 DIVERTICULAR PERFORATION 16 0.0078
143 HAEMATOLOGICAL INFECTION 19 0.0078
144 CHROMATURIA 175 0.0077
145 FEEDING DISORDER 157 0.0077
146 OROPHARYNGEAL DISCOMFORT 69 0.0076
147 LUNG CANCER METASTATIC 22 0.0076
148 PULMONARY ARTERIAL HYPERTENSION 110 0.0076
149 CORONAVIRUS INFECTION 50 0.0076
150 RESPIRATORY FAILURE 547 0.0075
151 DERMATOMYOSITIS 19 0.0075
152 RECTAL HAEMORRHAGE 322 0.0075
153 HYPOPNOEA 26 0.0075
154 INTESTINAL ISCHAEMIA 41 0.0074
155 DYSPNOEA 4179 0.0074
156 GASTROINTESTINAL PERFORATION 30 0.0072
157 INCREASED TENDENCY TO BRUISE 66 0.0072
158 MUSCULOSKELETAL CHEST PAIN 110 0.0071
159 LOWER RESPIRATORY TRACT CONGESTION 12 0.0071
160 DEFAECATION URGENCY 49 0.0070
161 HAEMORRHOIDS 136 0.0070
162 DECREASED ACTIVITY 75 0.0069
163 PNEUMONIA BACTERIAL 63 0.0069
164 ILLNESS 707 0.0069
165 STENT PLACEMENT 55 0.0068
166 PANCREATIC FAILURE 12 0.0068
167 PULMONARY THROMBOSIS 74 0.0068
168 SKIN HYPERTROPHY 19 0.0068
169 DIVERTICULITIS 187 0.0067
170 CORONARY ARTERIAL STENT INSERTION 34 0.0067
171 PULSELESS ELECTRICAL ACTIVITY 28 0.0067
172 RESPIRATORY TRACT INFECTION 174 0.0067
173 THROAT CLEARING 25 0.0067
174 GASTRIC PERFORATION 18 0.0066
175 FREQUENT BOWEL MOVEMENTS 178 0.0066
176 ANAL HAEMORRHAGE 18 0.0064
177 DRUG INTOLERANCE 618 0.0064
178 DRY THROAT 65 0.0064
179 FAECES PALE 14 0.0063
180 DUODENAL ULCER HAEMORRHAGE 18 0.0063
181 HYPERVOLAEMIA 31 0.0063
182 BRONCHIECTASIS 42 0.0062
183 VOMITING PROJECTILE 18 0.0062
184 HYPOPHAGIA 159 0.0062
185 EARLY SATIETY 12 0.0062
186 BRAIN NATRIURETIC PEPTIDE INCREASED 19 0.0062
187 EYE CONTUSION 13 0.0061
188 RIGHT VENTRICULAR FAILURE 43 0.0061
189 LIVER DISORDER 270 0.0061
190 NAUSEA 4818 0.0061
191 LISTLESS 20 0.0061
192 VOMITING 2828 0.0060
193 HEPATIC ENZYME ABNORMAL 30 0.0060
194 RESPIRATORY TRACT INFECTION VIRAL 14 0.0060
195 FORCED EXPIRATORY VOLUME DECREASED 17 0.0060
196 PNEUMONIA VIRAL 19 0.0060
197 GASTROOESOPHAGEAL REFLUX DISEASE 477 0.0059
198 COLITIS MICROSCOPIC 28 0.0059
199 BLOOD PRESSURE DIASTOLIC ABNORMAL 15 0.0059
200 CARDIAC PACEMAKER INSERTION 35 0.0059
201 ABNORMAL FAECES 48 0.0059
202 DYSPEPSIA 570 0.0058
203 FOOD INTOLERANCE 21 0.0057
204 DENTAL OPERATION 14 0.0057
205 ABDOMINAL DISTENSION 589 0.0056
206 BLOOD URINE PRESENT 107 0.0056
207 DEHYDRATION 743 0.0056
208 GALLBLADDER OPERATION 22 0.0054
209 ACUTE CORONARY SYNDROME 45 0.0054
210 CHOLECYSTITIS INFECTIVE 15 0.0054
211 TRANSAMINASES INCREASED 120 0.0054
212 COVID-19 PNEUMONIA 63 0.0053
213 NEPHROTIC SYNDROME 36 0.0052
214 ABDOMINAL TENDERNESS 26 0.0052
215 GASTRIC INFECTION 20 0.0052
216 ERUCTATION 101 0.0052
217 HYPOVENTILATION 17 0.0052
218 BLOOD MAGNESIUM DECREASED 45 0.0052
219 RHINORRHOEA 334 0.0052
220 ABDOMINAL RIGIDITY 14 0.0052
221 RHINOVIRUS INFECTION 20 0.0051
222 AORTIC ANEURYSM 39 0.0051
223 THERAPY NON-RESPONDER 226 0.0050
224 DYSPHONIA 294 0.0050
225 COLITIS 190 0.0050
226 PAINFUL RESPIRATION 12 0.0050
227 EMPHYSEMA 50 0.0050
228 REGURGITATION 17 0.0049
229 OESOPHAGEAL DISORDER 19 0.0049
230 RESPIRATORY DISORDER 147 0.0049
231 GASTRIC ULCER HAEMORRHAGE 27 0.0049
232 APHONIA 68 0.0049
233 PANCREATIC DISORDER 24 0.0049
234 HEPATOTOXICITY 108 0.0048
235 BLOOD IRON DECREASED 57 0.0048
236 HIATUS HERNIA 62 0.0048
237 HYPERSOMNIA 137 0.0048
238 PNEUMONIA 1543 0.0048
239 POLYMYALGIA RHEUMATICA 15 0.0047
240 ASTHENIA 1760 0.0047
241 PNEUMONITIS 127 0.0047
242 BLOOD PRESSURE SYSTOLIC DECREASED 21 0.0046
243 EPIGASTRIC DISCOMFORT 18 0.0046
244 BLOOD POTASSIUM DECREASED 137 0.0046
245 CHOLECYSTECTOMY 52 0.0045
246 SINUS HEADACHE 27 0.0045
247 HEART VALVE INCOMPETENCE 13 0.0045
248 BLOOD POTASSIUM ABNORMAL 12 0.0045
249 FOOD POISONING 24 0.0045
250 TRANSIENT ISCHAEMIC ATTACK 151 0.0045
251 LOWER GASTROINTESTINAL HAEMORRHAGE 33 0.0045
252 BREATH SOUNDS ABNORMAL 22 0.0045
253 RESPIRATORY RATE DECREASED 14 0.0045
254 DEVICE POWER SOURCE ISSUE 13 0.0044
255 OESOPHAGEAL ULCER 17 0.0044
256 ABDOMINAL PAIN 1024 0.0044
257 SINUS DISORDER 87 0.0044
258 DRY MOUTH 355 0.0044
259 LEFT VENTRICULAR FAILURE 15 0.0044
260 CARDIAC OPERATION 37 0.0043
261 HEART RATE ABNORMAL 24 0.0043
262 WEIGHT FLUCTUATION 45 0.0043
263 HEAD DISCOMFORT 76 0.0043
264 PULMONARY ALVEOLAR HAEMORRHAGE 24 0.0043
265 BLOOD PRESSURE ABNORMAL 85 0.0043
266 COVID-19 750 0.0043
267 DRUG-INDUCED LIVER INJURY 134 0.0043
268 GASTROENTERITIS VIRAL 77 0.0043
269 DYSCHEZIA 13 0.0043
270 DISEASE PROGRESSION 503 0.0042
271 DUODENITIS 13 0.0042
272 LARGE INTESTINE PERFORATION 29 0.0042
273 FLUID RETENTION 212 0.0042
274 HERNIA 80 0.0041
275 EATING DISORDER 88 0.0041
276 GASTROINTESTINAL INFECTION 37 0.0041
277 GASTROINTESTINAL NECROSIS 12 0.0041
278 PAROSMIA 31 0.0041
279 INTESTINAL PERFORATION 46 0.0041
280 PULMONARY MASS 61 0.0041
281 CACHEXIA 21 0.0041
282 ARTERIOSCLEROSIS CORONARY ARTERY 27 0.0041
283 HICCUPS 33 0.0040
284 COLITIS ISCHAEMIC 27 0.0040
285 SINUS CONGESTION 54 0.0040
286 GASTROINTESTINAL HAEMORRHAGE 333 0.0040
287 INTRACRANIAL ANEURYSM 16 0.0040
288 HEPATIC PAIN 17 0.0040
289 LUNG NEOPLASM 17 0.0040
290 CEREBRAL HAEMORRHAGE 142 0.0040
291 EMBOLISM VENOUS 12 0.0040
292 POST PROCEDURAL HAEMORRHAGE 46 0.0039
293 HAEMOGLOBIN INCREASED 18 0.0039
294 PERICARDIAL EFFUSION 91 0.0039
295 DEATH 3386 0.0039
296 EYE OPERATION 18 0.0039
297 FATIGUE 3033 0.0039
298 SUNBURN 29 0.0039
299 DIASTOLIC DYSFUNCTION 12 0.0039
300 HYPERTRANSAMINASAEMIA 27 0.0039
301 LUNG INFECTION 60 0.0039
302 CHEST PAIN 712 0.0038
303 BLOOD BLISTER 12 0.0038
304 INFLAMMATORY MARKER INCREASED 19 0.0038
305 DIVERTICULUM 27 0.0038
306 RESPIRATORY SYNCYTIAL VIRUS INFECTION 33 0.0038
307 GENERAL PHYSICAL HEALTH DETERIORATION 438 0.0038
308 CHEST DISCOMFORT 387 0.0038
309 PHOTOSENSITIVITY REACTION 62 0.0038
310 LUNG NEOPLASM MALIGNANT 154 0.0037
311 SNEEZING 84 0.0037
312 LIVER INJURY 91 0.0037
313 CHOLECYSTITIS 44 0.0037
314 OROPHARYNGEAL PAIN 340 0.0037
315 THERAPY PARTIAL RESPONDER 57 0.0037
316 YELLOW SKIN 17 0.0036
317 ANEURYSM 18 0.0036
318 REHABILITATION THERAPY 14 0.0036
319 SENSITIVITY TO WEATHER CHANGE 19 0.0036
320 HAEMORRHAGIC STROKE 28 0.0036
321 NASOPHARYNGITIS 660 0.0036
322 PROCEDURAL HAEMORRHAGE 14 0.0036
323 QUALITY OF LIFE DECREASED 48 0.0036
324 VENOUS THROMBOSIS 14 0.0036
325 PROSTATOMEGALY 14 0.0036
326 BLOOD SODIUM DECREASED 67 0.0036
327 DUODENAL ULCER 25 0.0035
328 GASTROINTESTINAL TOXICITY 17 0.0035
329 TONGUE DISCOMFORT 15 0.0035
330 HAEMATEMESIS 89 0.0035
331 BLOOD PRESSURE FLUCTUATION 84 0.0035
332 HEPATIC FIBROSIS 12 0.0035
333 NASAL CONGESTION 205 0.0035
334 LARGE INTESTINE POLYP 24 0.0035
335 INGUINAL HERNIA 21 0.0034
336 PULMONARY EMBOLISM 328 0.0034
337 POST PROCEDURAL INFECTION 28 0.0034
338 HEPATIC CIRRHOSIS 64 0.0034
339 RIB FRACTURE 70 0.0034
340 URINE ODOUR ABNORMAL 20 0.0034
341 MUSCLE ATROPHY 43 0.0034
342 SPINAL STENOSIS 14 0.0034
343 TOOTH EXTRACTION 42 0.0034
344 HYPOACUSIS 145 0.0034
345 CORONARY ARTERY OCCLUSION 46 0.0034
346 PRODUCT RESIDUE PRESENT 18 0.0033
347 FACIAL BONES FRACTURE 12 0.0033
348 POST PROCEDURAL COMPLICATION 64 0.0033
349 INFUSION SITE ERYTHEMA 28 0.0033
350 CANDIDA INFECTION 56 0.0033
351 SUDDEN DEATH 35 0.0033
352 HEADACHE 2071 0.0033
353 SKIN ATROPHY 19 0.0033
354 TERMINAL STATE 22 0.0033
355 CAROTID ARTERY OCCLUSION 12 0.0033
356 ASPIRATION 36 0.0033
357 MOUTH HAEMORRHAGE 24 0.0033
358 HYPERPHAGIA 13 0.0033
359 TENSION HEADACHE 14 0.0033
360 DEVICE OPERATIONAL ISSUE 14 0.0033
361 PAIN IN JAW 92 0.0032
362 DIZZINESS 1616 0.0032
363 MUSCLE STRAIN 28 0.0032
364 GOUT 58 0.0032
365 RENAL FUNCTION TEST ABNORMAL 15 0.0032
366 CARDIAC DYSFUNCTION 12 0.0032
367 DECREASED INTEREST 19 0.0032
368 HEART RATE DECREASED 113 0.0032
369 FRUSTRATION TOLERANCE DECREASED 26 0.0032
370 WHEEZING 190 0.0032
371 OESOPHAGITIS 35 0.0032
372 DIVERTICULUM INTESTINAL 14 0.0032
373 INFLUENZA 356 0.0032
374 ORAL CANDIDIASIS 42 0.0032
375 ARTERIOSCLEROSIS 30 0.0032
376 ELECTROLYTE IMBALANCE 37 0.0032
377 BLOOD PRESSURE INCREASED 486 0.0032
378 SKIN ABRASION 15 0.0032
379 CATHETER SITE INFECTION 12 0.0032
380 PERIPHERAL SWELLING 488 0.0032
381 CLOSTRIDIUM DIFFICILE INFECTION 69 0.0032
382 HEART RATE INCREASED 313 0.0032
383 RESPIRATORY RATE INCREASED 28 0.0032
384 PULMONARY OEDEMA 141 0.0031
385 ISCHAEMIC STROKE 56 0.0031
386 FEELING COLD 87 0.0031
387 ENTEROCOLITIS 18 0.0031
388 POOR QUALITY SLEEP 67 0.0031
389 ATRIOVENTRICULAR BLOCK 24 0.0031
390 RHINITIS 25 0.0031
391 COLON CANCER 46 0.0031
392 PERIPHERAL SENSORY NEUROPATHY 18 0.0031
393 HIP FRACTURE 99 0.0031
394 BUNDLE BRANCH BLOCK LEFT 13 0.0031
395 CONTUSION 295 0.0031
396 BLOOD TEST ABNORMAL 43 0.0031
397 ARTERIAL OCCLUSIVE DISEASE 24 0.0031
398 NAIL DISCOLOURATION 12 0.0030
399 PNEUMONIA FUNGAL 12 0.0030
400 MALNUTRITION 34 0.0030
401 ATRIAL FIBRILLATION 295 0.0030
402 INFUSION SITE PAIN 39 0.0030
403 LOCALISED OEDEMA 14 0.0030
404 HYPERTENSION 638 0.0030
405 COMPRESSION FRACTURE 16 0.0030
406 BRONCHITIS 221 0.0030
407 HIP SURGERY 16 0.0030
408 SKIN LACERATION 32 0.0029
409 CARDIAC DISORDER 275 0.0029
410 RENAL PAIN 31 0.0029
411 LIVER FUNCTION TEST ABNORMAL 85 0.0029
412 FAECALOMA 16 0.0029
413 BEDRIDDEN 38 0.0029
414 IRON DEFICIENCY 13 0.0029
415 PULMONARY CONGESTION 38 0.0029
416 SKIN CANCER 62 0.0029
417 MELAENA 63 0.0029
418 GALLBLADDER DISORDER 51 0.0029
419 HEPATIC STEATOSIS 53 0.0028
420 GAMMA-GLUTAMYLTRANSFERASE INCREASED 63 0.0028
421 SPINAL OPERATION 35 0.0028
422 HOSPICE CARE 28 0.0028
423 CHOLECYSTITIS ACUTE 16 0.0028
424 DYSGEUSIA 209 0.0028
425 POSTOPERATIVE WOUND INFECTION 19 0.0028
426 FEELING ABNORMAL 670 0.0028
427 CYSTITIS 89 0.0028
428 PERFORMANCE STATUS DECREASED 13 0.0028
429 URINARY TRACT INFECTION 472 0.0028
430 BLOOD PRESSURE DECREASED 183 0.0028
431 PROCEDURAL COMPLICATION 21 0.0027
432 VIRAL INFECTION 91 0.0027
433 MALIGNANT NEOPLASM PROGRESSION 280 0.0027
434 CARDIAC FAILURE 219 0.0027
435 LIMB INJURY 74 0.0027
436 INCREASED APPETITE 52 0.0027
437 PROSTATIC DISORDER 15 0.0027
438 GAIT INABILITY 90 0.0027
439 APPENDICITIS 25 0.0027
440 CEREBROVASCULAR ACCIDENT 451 0.0027
441 TOOTH INFECTION 35 0.0027
442 CHOLELITHIASIS 87 0.0027
443 RESPIRATORY DISTRESS 73 0.0026
444 THERAPY CHANGE 26 0.0026
445 CARDIAC FLUTTER 17 0.0026
446 MALAISE 1152 0.0026
447 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 137 0.0026
448 MUCOUS STOOLS 13 0.0026
449 EAR DISORDER 12 0.0026
450 FALL 872 0.0026
451 NEPHROLITHIASIS 120 0.0026
452 BRAIN FOG 41 0.0026
453 CHOKING 51 0.0026
454 ABDOMINAL PAIN LOWER 66 0.0026
455 CORONARY ARTERY BYPASS 15 0.0026
456 GASTROENTERITIS 38 0.0026
457 HEPATIC FUNCTION ABNORMAL 97 0.0026
458 FLUID INTAKE REDUCED 13 0.0026
459 HYPOTENSION 521 0.0026
460 POLLAKIURIA 108 0.0026
461 PNEUMOCYSTIS JIROVECII PNEUMONIA 26 0.0026
462 UMBILICAL HERNIA 12 0.0026
463 INFUSION SITE SWELLING 16 0.0025
464 FEMORAL NECK FRACTURE 13 0.0025
465 HEART RATE IRREGULAR 57 0.0025
466 METASTASES TO LYMPH NODES 17 0.0025
467 SLEEP APNOEA SYNDROME 48 0.0025
468 ULCER 40 0.0025
469 ANGINA PECTORIS 72 0.0025
470 PLEURAL EFFUSION 152 0.0025
471 KIDNEY INFECTION 49 0.0025
472 SPINAL FRACTURE 50 0.0025
473 OCULAR DISCOMFORT 28 0.0025
474 GINGIVAL BLEEDING 34 0.0025
475 BACK PAIN 577 0.0025
476 DERMATITIS ACNEIFORM 15 0.0025
477 CONCUSSION 19 0.0025
478 CARDIAC VALVE DISEASE 14 0.0024
479 UPPER RESPIRATORY TRACT INFECTION 113 0.0024
480 CARDIOMEGALY 30 0.0024
481 LETHARGY 140 0.0024
482 ARTHROPOD BITE 18 0.0024
483 SPINAL DISORDER 23 0.0024
484 JAUNDICE 65 0.0024
485 SKIN REACTION 34 0.0024
486 LOCALISED INFECTION 58 0.0024
487 VEIN DISORDER 12 0.0024
488 NASAL DISCOMFORT 19 0.0024
489 HAEMATURIA 82 0.0024
490 MUSCLE SPASMS 433 0.0024
491 BACTERIAL INFECTION 44 0.0024
492 PRODUCT USE COMPLAINT 37 0.0023
493 IMPAIRED HEALING 77 0.0023
494 HEAD INJURY 74 0.0023
495 INFECTION 338 0.0023
496 BLOOD BILIRUBIN INCREASED 63 0.0023
497 DECUBITUS ULCER 19 0.0023
498 LOWER RESPIRATORY TRACT INFECTION 106 0.0023
499 ASPHYXIA 19 0.0023
500 GASTRIC ULCER 44 0.0023
501 DEPRESSED MOOD 122 0.0023
502 PSYCHIATRIC SYMPTOM 17 0.0023
503 SALIVARY HYPERSECRETION 23 0.0023
504 BACK INJURY 25 0.0023
505 NECK PAIN 128 0.0023
506 DYSPHAGIA 217 0.0023
507 SKIN ULCER 59 0.0023
508 ANOSMIA 33 0.0023
509 MUSCULAR WEAKNESS 259 0.0023
510 POLYARTHRITIS 12 0.0023
511 NERVE COMPRESSION 21 0.0023
512 THROMBOSIS 183 0.0023
513 HEPATIC CYTOLYSIS 29 0.0023
514 APATHY 33 0.0023
515 SCIATICA 36 0.0023
516 SLUGGISHNESS 23 0.0023
517 CEREBRAL INFARCTION 55 0.0022
518 THIRST 40 0.0022
519 SYNCOPE 223 0.0022
520 INTESTINAL OBSTRUCTION 84 0.0022
521 HUNGER 31 0.0022
522 OEDEMA PERIPHERAL 268 0.0022
523 RENAL DISORDER 101 0.0022
524 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
525 IRON DEFICIENCY ANAEMIA 20 0.0022
526 CYANOSIS 34 0.0022
527 INTENTIONAL PRODUCT USE ISSUE 188 0.0021
528 CARDIAC FAILURE CONGESTIVE 172 0.0021
529 SINUSITIS 219 0.0021
530 GINGIVAL PAIN 17 0.0021
531 CATARACT 127 0.0021
532 COLECTOMY 12 0.0021
533 HAEMORRHAGE 222 0.0021
534 OEDEMA 115 0.0021
535 BLADDER DISORDER 21 0.0021
536 DEMENTIA 59 0.0021
537 INTENTIONAL DOSE OMISSION 60 0.0021
538 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
539 EYE HAEMORRHAGE 28 0.0021
540 HEPATIC FAILURE 63 0.0021
541 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
542 SURGERY 122 0.0021
543 IMMUNODEFICIENCY 31 0.0021
544 HYPERVENTILATION 12 0.0021
545 LIMB DISCOMFORT 64 0.0021
546 VASCULITIS 24 0.0021
547 EAR DISCOMFORT 21 0.0020
548 LOSS OF CONSCIOUSNESS 262 0.0020
549 ACUTE MYOCARDIAL INFARCTION 60 0.0020
550 BLOOD POTASSIUM INCREASED 33 0.0020
551 FLANK PAIN 19 0.0020
552 LIGAMENT SPRAIN 20 0.0020
553 ARTHRITIS 159 0.0020
554 METASTASES TO CENTRAL NERVOUS SYSTEM 26 0.0020
555 DYSURIA 74 0.0020
556 ORTHOSTATIC HYPOTENSION 35 0.0020
557 PROTEINURIA 38 0.0020
558 HEPATITIS 51 0.0020
559 DENTAL CARIES 22 0.0020
560 CORONARY ARTERY DISEASE 60 0.0020
561 GASTRITIS 52 0.0020
562 PERIPHERAL COLDNESS 27 0.0020
563 BRONCHOSPASM 28 0.0020
564 BALANCE DISORDER 169 0.0020
565 AMNESIA 127 0.0020
566 IMPAIRED QUALITY OF LIFE 28 0.0019
567 SEPSIS 217 0.0019
568 HAEMORRHAGE INTRACRANIAL 29 0.0019
569 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 93 0.0019
570 CHOLANGITIS 12 0.0019
571 CHILLS 225 0.0019
572 WRIST FRACTURE 23 0.0019
573 MUSCULOSKELETAL DISCOMFORT 33 0.0019
574 DEPRESSION 436 0.0019
575 IRRITABLE BOWEL SYNDROME 41 0.0019
576 HEPATOCELLULAR INJURY 27 0.0019
577 STOMATITIS 115 0.0019
578 INSOMNIA 500 0.0019
579 BREAST PAIN 20 0.0019
580 ALANINE AMINOTRANSFERASE INCREASED 115 0.0019
581 NEOPLASM MALIGNANT 125 0.0019
582 MEMORY IMPAIRMENT 257 0.0019
583 PROCTALGIA 12 0.0019
584 HAEMOGLOBIN ABNORMAL 12 0.0019
585 APHASIA 56 0.0019
586 AUTOIMMUNE DISORDER 18 0.0018
587 MICTURITION URGENCY 21 0.0018
588 BODY TEMPERATURE DECREASED 18 0.0018
589 CARDIOMYOPATHY 27 0.0018
590 TOOTHACHE 33 0.0018
591 METASTASIS 13 0.0018
592 SLEEP DISORDER 128 0.0018
593 HERPES ZOSTER 104 0.0018
594 BRONCHOPULMONARY ASPERGILLOSIS 14 0.0018
595 CARDIAC FAILURE ACUTE 12 0.0018
596 LEUKAEMIA 17 0.0018
597 PNEUMONIA ASPIRATION 45 0.0018
598 EOSINOPHIL COUNT INCREASED 15 0.0018
599 WHITE BLOOD CELL COUNT INCREASED 69 0.0018
600 CYTOPENIA 22 0.0018
601 GASTROINTESTINAL INFLAMMATION 14 0.0018
602 UPPER GASTROINTESTINAL HAEMORRHAGE 30 0.0018
603 PANCREATITIS 94 0.0018
604 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
605 HIP ARTHROPLASTY 27 0.0018
606 RENAL CYST 14 0.0018
607 CIRCULATORY COLLAPSE 30 0.0018
608 MACULAR DEGENERATION 21 0.0018
609 VERTIGO 107 0.0018
610 ASPARTATE AMINOTRANSFERASE INCREASED 93 0.0017
611 GLYCOSYLATED HAEMOGLOBIN INCREASED 44 0.0017
612 HAEMATOMA 45 0.0017
613 NOCTURIA 21 0.0017
614 PETECHIAE 18 0.0017
615 BACK DISORDER 28 0.0017
616 ANAEMIA 328 0.0017
617 SPEECH DISORDER 90 0.0017
618 HYPERTENSIVE CRISIS 19 0.0017
619 INCONTINENCE 18 0.0017
620 PHARYNGITIS 21 0.0017
621 TACHYPNOEA 23 0.0017
622 HYPOKALAEMIA 78 0.0017
623 BLOOD GLUCOSE DECREASED 81 0.0017
624 SKIN HAEMORRHAGE 25 0.0017
625 PRESYNCOPE 41 0.0017
626 EMBOLISM 14 0.0017
627 MYOCARDIAL INFARCTION 294 0.0017
628 JOINT INJURY 36 0.0017
629 TOOTH ABSCESS 17 0.0017
630 SENSATION OF FOREIGN BODY 14 0.0017
631 TONGUE DISORDER 12 0.0017
632 INITIAL INSOMNIA 17 0.0017
633 ORAL PAIN 37 0.0017
634 INTENTIONAL UNDERDOSE 12 0.0016
635 PHARYNGEAL SWELLING 16 0.0016
636 BLOOD THYROID STIMULATING HORMONE INCREASED 15 0.0016
637 CONDITION AGGRAVATED 495 0.0016
638 NERVOUSNESS 85 0.0016
639 FEELING JITTERY 31 0.0016
640 KNEE OPERATION 16 0.0016
641 HAEMOGLOBIN DECREASED 167 0.0016
642 SMALL INTESTINAL OBSTRUCTION 20 0.0016
643 PRODUCT DOSE OMISSION IN ERROR 46 0.0016
644 C-REACTIVE PROTEIN INCREASED 59 0.0016
645 ALOPECIA 316 0.0016
646 NEPHROPATHY TOXIC 18 0.0016
647 BASAL CELL CARCINOMA 25 0.0016
648 OSTEOMYELITIS 29 0.0016
649 URINE OUTPUT DECREASED 14 0.0016
650 NAIL DISORDER 14 0.0016
651 CARDIAC ARREST 131 0.0016
652 PROCEDURAL PAIN 44 0.0016
653 COMPLICATION ASSOCIATED WITH DEVICE 23 0.0016
654 SUBARACHNOID HAEMORRHAGE 16 0.0016
655 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
656 MYOSITIS 14 0.0016
657 GLAUCOMA 30 0.0016
658 UPPER LIMB FRACTURE 31 0.0016
659 WOUND INFECTION 17 0.0016
660 PYREXIA 537 0.0016
661 GAIT DISTURBANCE 296 0.0015
662 MOBILITY DECREASED 111 0.0015
663 ARRHYTHMIA 73 0.0015
664 JOINT SWELLING 186 0.0015
665 SUBDURAL HAEMATOMA 22 0.0015
666 GENERALISED OEDEMA 19 0.0015
667 PRODUCT ADMINISTRATION ERROR 31 0.0015
668 TOOTH DISORDER 34 0.0015
669 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
670 PSEUDOMONAS INFECTION 13 0.0015
671 TRICUSPID VALVE INCOMPETENCE 12 0.0015
672 DISCOMFORT 92 0.0015
673 EXTRA DOSE ADMINISTERED 61 0.0015
674 MYOPATHY 13 0.0015
675 ATRIAL FLUTTER 12 0.0015
676 TREMOR 248 0.0015
677 MYOCARDIAL ISCHAEMIA 17 0.0015
678 FULL BLOOD COUNT DECREASED 30 0.0015
679 LYMPHOMA 23 0.0015
680 URINARY INCONTINENCE 44 0.0015
681 MULTIPLE ORGAN DYSFUNCTION SYNDROME 42 0.0015
682 NEURALGIA 36 0.0015
683 SOMNOLENCE 297 0.0015
684 RENAL IMPAIRMENT 123 0.0015
685 MOVEMENT DISORDER 47 0.0015
686 HELICOBACTER INFECTION 15 0.0015
687 CARDIO-RESPIRATORY ARREST 61 0.0015
688 MIDDLE INSOMNIA 27 0.0014
689 HEAVY MENSTRUAL BLEEDING 13 0.0014
690 PAIN IN EXTREMITY 425 0.0014
691 DYSSTASIA 42 0.0014
692 OBSTRUCTIVE AIRWAYS DISORDER 16 0.0014
693 VITAMIN D DEFICIENCY 14 0.0014
694 WEIGHT INCREASED 319 0.0014
695 PALPITATIONS 166 0.0014
696 SKIN DISCOLOURATION 65 0.0014
697 ARTHRALGIA 587 0.0014
698 OSTEOPOROSIS 58 0.0014
699 UROSEPSIS 13 0.0014
700 VITAMIN D DECREASED 12 0.0014
701 NIGHT SWEATS 45 0.0014
702 HYPOAESTHESIA ORAL 21 0.0014
703 MYALGIA 235 0.0014
704 SQUAMOUS CELL CARCINOMA 13 0.0014
705 RESTLESS LEGS SYNDROME 25 0.0014
706 HYPOCALCAEMIA 26 0.0014
707 FRACTURE 26 0.0014
708 THROAT TIGHTNESS 37 0.0014
709 GROIN PAIN 12 0.0014
710 METASTASES TO LIVER 24 0.0014
711 SARS-COV-2 TEST POSITIVE 18 0.0014
712 TOOTH FRACTURE 15 0.0014
713 IMMUNOSUPPRESSION 12 0.0014
714 INFLAMMATION 70 0.0014
715 MUSCULOSKELETAL PAIN 71 0.0014
716 FUNGAL INFECTION 45 0.0013
717 ANXIETY 381 0.0013
718 INFLAMMATORY BOWEL DISEASE 13 0.0013
719 VITREOUS FLOATERS 13 0.0013
720 SKIN DISORDER 44 0.0013
721 ACUTE HEPATIC FAILURE 18 0.0013
722 THERAPEUTIC RESPONSE UNEXPECTED 59 0.0013
723 CHOLESTASIS 25 0.0013
724 ACUTE KIDNEY INJURY 199 0.0013
725 BLOOD GLUCOSE ABNORMAL 24 0.0013
726 THYROID DISORDER 20 0.0013
727 PANCREATITIS ACUTE 29 0.0013
728 ILEUS 16 0.0013
729 RASH MACULAR 45 0.0013
730 SEPTIC SHOCK 56 0.0013
731 EAR PAIN 25 0.0013
732 HEPATIC ENCEPHALOPATHY 12 0.0013
733 KNEE ARTHROPLASTY 27 0.0013
734 SWELLING 120 0.0013
735 FEBRILE NEUTROPENIA 85 0.0013
736 EYE PRURITUS 43 0.0013
737 FLUSHING 130 0.0013
738 BODY TEMPERATURE INCREASED 26 0.0013
739 DISORIENTATION 50 0.0013
740 HYPONATRAEMIA 71 0.0013
741 TEMPERATURE INTOLERANCE 13 0.0013
742 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
743 POLYNEUROPATHY 15 0.0013
744 DIABETES MELLITUS 95 0.0012
745 FACE OEDEMA 21 0.0012
746 EYE INFECTION 14 0.0012
747 PRODUCT PHYSICAL ISSUE 25 0.0012
748 MENTAL IMPAIRMENT 30 0.0012
749 FLUID OVERLOAD 18 0.0012
750 RESPIRATORY ARREST 34 0.0012
751 THROMBOTIC MICROANGIOPATHY 12 0.0012
752 CONFUSIONAL STATE 198 0.0012
753 LACRIMATION INCREASED 37 0.0012
754 INTENTIONAL PRODUCT MISUSE 106 0.0012
755 THERAPY INTERRUPTED 86 0.0012
756 OSTEOARTHRITIS 51 0.0012
757 PAIN 735 0.0012
758 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
759 THERAPY CESSATION 61 0.0012
760 BLOOD GLUCOSE FLUCTUATION 13 0.0012
761 DEAFNESS 31 0.0012
762 VISUAL IMPAIRMENT 146 0.0012
763 ACCIDENT 14 0.0012
764 ADVERSE DRUG REACTION 105 0.0012
765 URINARY RETENTION 39 0.0012
766 DISTURBANCE IN ATTENTION 63 0.0012
767 HOT FLUSH 88 0.0012
768 ANKLE FRACTURE 18 0.0012
769 TACHYCARDIA 103 0.0012
770 SKIN INFECTION 13 0.0012
771 HYPOTHYROIDISM 37 0.0012
772 METASTASES TO BONE 19 0.0012
773 VENTRICULAR EXTRASYSTOLES 12 0.0012
774 ILL-DEFINED DISORDER 70 0.0012
775 CELLULITIS 58 0.0011
776 MITRAL VALVE INCOMPETENCE 13 0.0011
777 LOWER LIMB FRACTURE 22 0.0011
778 MASS 16 0.0011
779 IMMUNE SYSTEM DISORDER 15 0.0011
780 BLOOD CHOLESTEROL INCREASED 53 0.0011
781 COLD SWEAT 20 0.0011
782 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
783 FEMUR FRACTURE 35 0.0011
784 PANIC ATTACK 41 0.0011
785 STAPHYLOCOCCAL INFECTION 37 0.0011
786 DEEP VEIN THROMBOSIS 72 0.0011
787 DEVICE RELATED INFECTION 17 0.0011
788 NEUTROPHIL COUNT DECREASED 45 0.0011
789 BLOOD CREATININE INCREASED 72 0.0011
790 BACTERAEMIA 13 0.0011
791 DELIRIUM 38 0.0011
792 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 197 0.0011
793 RHEUMATOID ARTHRITIS 124 0.0011
794 ORAL DISCOMFORT 15 0.0011
795 DIPLOPIA 28 0.0011
796 ROAD TRAFFIC ACCIDENT 45 0.0011
797 BURSITIS 13 0.0011
798 RASH PRURITIC 58 0.0011
799 MUCOSAL INFLAMMATION 28 0.0011
800 DEVICE OCCLUSION 15 0.0011
801 MOOD ALTERED 29 0.0011
802 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
803 SKIN LESION 29 0.0011
804 CARDIOGENIC SHOCK 15 0.0010
805 LYMPHADENOPATHY 37 0.0010
806 METASTASES TO LUNG 12 0.0010
807 PRODUCT DOSE OMISSION ISSUE 304 0.0010
808 HYPOKINESIA 15 0.0010
809 VENTRICULAR TACHYCARDIA 17 0.0010
810 EJECTION FRACTION DECREASED 16 0.0010
811 PALLOR 28 0.0010
812 DRUG INTERACTION 163 0.0010
813 ORAL HERPES 20 0.0010
814 INFLUENZA LIKE ILLNESS 84 0.0010
815 THINKING ABNORMAL 19 0.0010
816 VISION BLURRED 139 0.0010
817 FEELING HOT 62 0.0010
818 HYPOMAGNESAEMIA 14 0.0010
819 HEMIPARESIS 17 0.0010
820 NEUROPATHY PERIPHERAL 95 0.0010
821 OFF LABEL USE 870 0.0010
822 SCAR 17 0.0010
823 DEVICE FAILURE 15 0.0010
824 RASH 425 0.0010
825 TINNITUS 44 0.0010
826 HYPOAESTHESIA 143 0.0010
827 ASCITES 28 0.0010
828 FOOT FRACTURE 18 0.0009
829 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
830 RED BLOOD CELL COUNT DECREASED 27 0.0009
831 PROSTATIC SPECIFIC ANTIGEN INCREASED 13 0.0009
832 RENAL FAILURE 125 0.0009
833 ROTATOR CUFF SYNDROME 12 0.0009
834 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16 0.0009
835 PROSTATE CANCER 75 0.0009
836 UNRESPONSIVE TO STIMULI 24 0.0009
837 OSTEONECROSIS OF JAW 23 0.0009
838 ACCIDENTAL OVERDOSE 34 0.0009
839 PRURITUS 357 0.0009
840 BLINDNESS 37 0.0009
841 CYTOMEGALOVIRUS INFECTION 15 0.0009
842 MOUTH ULCERATION 19 0.0009
843 MIGRAINE 86 0.0009
844 PLATELET COUNT DECREASED 96 0.0009
845 COAGULOPATHY 15 0.0009
846 RASH ERYTHEMATOUS 43 0.0009
847 IMPAIRED GASTRIC EMPTYING 12 0.0009
848 TREATMENT NONCOMPLIANCE 48 0.0009
849 DYSARTHRIA 33 0.0009
850 UNEVALUABLE EVENT 66 0.0009
851 ABNORMAL DREAMS 24 0.0009
852 GASTRIC CANCER 22 0.0009
853 WHITE BLOOD CELL COUNT DECREASED 94 0.0009
854 MUSCLE TIGHTNESS 14 0.0009
855 MENTAL STATUS CHANGES 24 0.0009
856 ARTHROPATHY 48 0.0009
857 HOSPITALISATION 132 0.0009
858 DEVICE USE ISSUE 15 0.0009
859 GLOSSODYNIA 19 0.0008
860 HYPERHIDROSIS 109 0.0008
861 LIP SWELLING 28 0.0008
862 TENDONITIS 13 0.0008
863 MYELODYSPLASTIC SYNDROME 12 0.0008
864 MEDICATION ERROR 46 0.0008
865 LABORATORY TEST ABNORMAL 24 0.0008
866 NEOPLASM PROGRESSION 28 0.0008
867 RASH PAPULAR 18 0.0008
868 HYPERGLYCAEMIA 29 0.0008
869 OSTEOPENIA 12 0.0008
870 HEPATIC CANCER 19 0.0008
871 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 56 0.0008
872 WOUND 22 0.0008
873 INCORRECT PRODUCT ADMINISTRATION DURATION 17 0.0008
874 DRY SKIN 103 0.0008
875 BURNING SENSATION 54 0.0008
876 BLOOD GLUCOSE INCREASED 144 0.0008
877 DRY EYE 38 0.0008
878 SYSTEMIC LUPUS ERYTHEMATOSUS 27 0.0008
879 EYE DISORDER 25 0.0008
880 SWELLING FACE 49 0.0008
881 EAR INFECTION 20 0.0008
882 EYE PAIN 42 0.0007
883 PAIN OF SKIN 20 0.0007
884 HYPERKALAEMIA 26 0.0007
885 BONE MARROW FAILURE 15 0.0007
886 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
887 PARAESTHESIA 115 0.0007
888 BLISTER 41 0.0007
889 PERITONITIS 15 0.0007
890 THROMBOCYTOPENIA 80 0.0007
891 NEUTROPENIA 97 0.0007
892 CARDIOVASCULAR DISORDER 18 0.0007
893 SEIZURE 81 0.0007
894 BONE PAIN 41 0.0007
895 EYE SWELLING 26 0.0007
896 NIGHTMARE 24 0.0007
897 COLITIS ULCERATIVE 31 0.0007
898 ABSCESS 11 0.0007
899 IRRITABILITY 41 0.0007
900 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
901 DRUG ERUPTION 12 0.0007
902 HYPERSENSITIVITY 122 0.0007
903 ECZEMA 34 0.0006
904 SKIN EXFOLIATION 54 0.0006
905 HYPOGLYCAEMIA 30 0.0006
906 DEVICE MALFUNCTION 43 0.0006
907 HAEMATOCRIT DECREASED 12 0.0006
908 INCORRECT DOSE ADMINISTERED 138 0.0006
909 BRADYCARDIA 32 0.0006
910 URTICARIA 101 0.0006
911 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
912 HALLUCINATION 45 0.0006
913 AGRANULOCYTOSIS 11 0.0006
914 OCULAR HYPERAEMIA 28 0.0006
915 LEUKOPENIA 29 0.0006
916 TOOTH LOSS 12 0.0006
917 FIBROMYALGIA 14 0.0006
918 PRODUCT USE IN UNAPPROVED INDICATION 142 0.0006
919 DERMATITIS 12 0.0006
920 JOINT STIFFNESS 15 0.0006
921 MUSCULOSKELETAL STIFFNESS 50 0.0006
922 MOOD SWINGS 18 0.0006
923 TYPE 2 DIABETES MELLITUS 19 0.0006
924 ASTHMA 63 0.0006
925 COGNITIVE DISORDER 26 0.0006
926 DRUG EFFECT INCOMPLETE 20 0.0006
927 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 30 0.0005
928 THERAPEUTIC RESPONSE SHORTENED 18 0.0005
929 ERYTHEMA 111 0.0005
930 PRODUCT USE ISSUE 101 0.0005
931 METABOLIC ACIDOSIS 17 0.0005
932 ENCEPHALOPATHY 13 0.0005
933 SHOCK 12 0.0005
934 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
935 FEAR 14 0.0005
936 DRUG INEFFECTIVE 673 0.0005
937 ERECTILE DYSFUNCTION 13 0.0005
938 DRUG RESISTANCE 13 0.0005
939 ANGER 17 0.0005
940 ADVERSE EVENT 46 0.0005
941 EMOTIONAL DISORDER 15 0.0005
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 97 0.0005
943 CHRONIC KIDNEY DISEASE 36 0.0005
944 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
945 PANCYTOPENIA 26 0.0005
946 VAGINAL HAEMORRHAGE 20 0.0005
947 THERAPEUTIC RESPONSE DECREASED 27 0.0004
948 AGITATION 32 0.0004
949 ACNE 33 0.0004
950 TREATMENT FAILURE 36 0.0004
951 OSTEONECROSIS 14 0.0004
952 EPILEPSY 13 0.0004
953 BLADDER CANCER 25 0.0004
954 PANCREATIC CARCINOMA 12 0.0004
955 RESTLESSNESS 15 0.0004
956 OESOPHAGEAL CARCINOMA 12 0.0004
957 RENAL INJURY 12 0.0004
958 COMA 19 0.0004
959 NERVOUS SYSTEM DISORDER 12 0.0004
960 ANGIOEDEMA 17 0.0004
961 SWOLLEN TONGUE 12 0.0004
962 RHABDOMYOLYSIS 16 0.0004
963 DISEASE RECURRENCE 18 0.0004
964 MENTAL DISORDER 16 0.0004
965 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 16 0.0003
966 PRODUCT STORAGE ERROR 27 0.0003
967 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
968 DYSKINESIA 12 0.0003
969 SKIN BURNING SENSATION 21 0.0003
970 DEVICE ISSUE 26 0.0003
971 EYE IRRITATION 16 0.0003
972 SUICIDAL IDEATION 24 0.0003
973 SKIN IRRITATION 12 0.0003
974 PRODUCT DOSE OMISSION 17 0.0003
975 INJURY 18 0.0003
976 UNDERDOSE 18 0.0002
977 PRODUCT QUALITY ISSUE 33 0.0002
978 BREAST CANCER 22 0.0002
979 PSORIASIS 30 0.0002
980 ANAPHYLACTIC REACTION 12 0.0002
981 OVERDOSE 45 0.0002
982 INJECTION SITE ERYTHEMA 25 0.0002
983 INFUSION RELATED REACTION 12 0.0002
984 TOXICITY TO VARIOUS AGENTS 30 0.0002
985 INJECTION SITE BRUISING 14 0.0002
986 NO ADVERSE EVENT 31 0.0002
987 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
988 EMOTIONAL DISTRESS 15 0.0001
989 INJECTION SITE PAIN 32 0.0001